Key Activities and Accomplishments
HIV Treatment Program
• Collaborative efforts between CDC and MOHCC have put over 1.1 million Zimbabweans on antiretroviral treatment (ART), translating to approximately 80% coverage of PLHIV across the country. This is largely the result of technical, direct human resource support, and strong coordination among stakeholders.
Voluntary Medical Male Circumcision (VMMC)
• VMMC is the cornerstone of biomedical HIV prevention in Zimbabwe; an estimated one new HIV infection is averted with every 8 male circumcisions. In FY 2017, CDC supported over 100,000 circumcisions.
Surveys, Surveillance and Program Information
• The first report of the Zimbabwe Population-Based HIV Impact Assessment (ZIMPHIA), provided the first national level HIV incidence of 0.47% among adults 15-64 years: 0.33% among males and 0.60% among females. This corresponds to approximately 33,000 new cases of HIV annually among persons aged 15 to 64 in Zimbabwe. HIV prevalence among adults aged 15 to 64 in Zimbabwe is 14.1%: 12.0% among males and 16.0% among females. This corresponds to approximately 1.2 million persons aged 15 to 64 living with HIV in Zimbabwe. (ZIMPHIA 2016)
• The country completed round two of the preventing mother to child transmission (PMTCT) Effectiveness Survey (2016-2017). The survey showed increase in ART uptake in the preconception and pregnancy phases in adult women. Population 81.2% at six weeks and 85.2%, at 12 months postpartum.
• A national tablet-based electronic health record (EHR) system has been piloted by CDC, endorsed by the MOHCC at the end of 2016. The MOHCC has proactively supported decentralization of patients so the system will support de-duplication of data. The system is being implemented in the capital, Harare, with plans for nationwide rollout subject to funding availability.
• Recognizing the high risk of TB infection and transmission in health facilities, CDC is partnering with MOHCC to develop and implement a national policy for annual TB screening for all health care workers across Zimbabwe.
• MOHCC National Program Data shows the availability of viral load testing for PLHIV on ART increased from 5% in December 2015 to nearly 40% in 2017, after CDC placed 6 new platforms in labs across the country. Capacity building continues through proficiency testing and strong quality management